Suppr超能文献

慢性脑卒中患者临床和实验室步态评估中的心肺反应。

Cardiopulmonary Responses During Clinical and Laboratory Gait Assessments in People With Chronic Stroke.

机构信息

Shirley Ryan AbilityLab, Chicago, Illinois. She is a board-certified neurologic clinical specialist.

Shirley Ryan AbilityLab.

出版信息

Phys Ther. 2019 Jan 1;99(1):86-97. doi: 10.1093/ptj/pzy128.

Abstract

BACKGROUND

The 6-Minute Walk Test (6MWT) is a common clinical assessment used to evaluate locomotor function in patients after stroke. Previous work suggests the 6MWT can estimate peak metabolic capacity (VO2peak) without cardiorespiratory assessments during graded exercise tests (GXTs), which may assist with exercise prescription. However, selected research also indicated increased heart rates (HRs) during 6MWTs beyond levels considered safe without GXTs.

OBJECTIVE

The goal of this study was to examine cardiorespiratory responses during 6MWTs and GXTs in individuals with chronic stroke and their associations with demographic or clinical characteristics.

DESIGN

The study used a cross-sectional observational design.

METHODS

Cardiorespiratory responses were assessed during 6MWTs at self-selected velocity (SSV) and fastest velocity (FV), and during GXTs. Secondary assessments included the lower extremity Fugl-Meyer Assessment, Functional Gait Assessment, gait speeds, and daily stepping activity. Correlation and regression analyses were used to evaluate associations between locomotor performance, cardiorespiratory responses, and clinical and demographic characteristics.

RESULTS

Average HRs during 6MWT-FV were 72% to 76% of the age-predicted maximum (HRmax), with 20% of participants exceeding 85% predicted HRmax. When normalized to HRs during GXTs, HRs during 6MWT-FV were 86% to 88% of observed HRmax. Primary predictors of increased HRs during 6MWTs were resting HR, body mass index, and daily stepping. Distance during 6MWT-FV was a significant predictor of VO2peak in combination with other variables. Electrocardiographic abnormalities were observed in >80% of participants at rest and 31% demonstrated distinct abnormalities during GXTs, which were not related to 6MWT or GXT performance.

LIMITATIONS

In addition to sample size, a primary limitation involved the ability to accurately predict or measure HRmax in patients with motor dysfunction after stroke.

CONCLUSIONS

Cardiac responses were higher than anticipated during 6MWTs and often exceeded recommended HR thresholds. Clinicians should closely monitor cardiorespiratory responses during 6MWTs.

摘要

背景

6 分钟步行测试(6MWT)是一种常用于评估卒中后患者运动功能的临床评估方法。先前的研究表明,6MWT 可以在没有分级运动测试(GXT)的情况下估计峰值代谢能力(VO2peak),这可能有助于制定运动处方。然而,一些研究也表明,在没有 GXT 的情况下,6MWT 中的心率(HR)超过了被认为是安全的水平。

目的

本研究旨在检查慢性卒中患者在 6MWT 和 GXT 中的心肺反应及其与人口统计学或临床特征的关系。

设计

本研究采用了横断面观察性设计。

方法

在自我选择速度(SSV)和最快速度(FV)下进行 6MWT 时以及在 GXT 期间评估心肺反应。次要评估包括下肢 Fugl-Meyer 评估、功能性步态评估、步态速度和日常步数活动。使用相关和回归分析来评估运动表现、心肺反应与临床和人口统计学特征之间的关系。

结果

6MWT-FV 期间的平均 HR 为年龄预测最大 HR(HRmax)的 72%至 76%,有 20%的参与者超过了预测 HRmax 的 85%。当与 GXT 期间的 HR 进行归一化时,6MWT-FV 期间的 HR 为观察到的 HRmax 的 86%至 88%。6MWT 期间 HR 增加的主要预测因素是静息 HR、体重指数和日常步数。6MWT-FV 的距离与其他变量结合是 VO2peak 的重要预测因子。在休息时,超过 80%的参与者存在心电图异常,在 31%的参与者在 GXT 期间存在明显的异常,这些异常与 6MWT 或 GXT 表现无关。

局限性

除了样本量外,主要的局限性还涉及到在患有运动功能障碍的卒中患者中准确预测或测量 HRmax 的能力。

结论

在 6MWT 期间,心脏反应高于预期,且经常超过推荐的 HR 阈值。临床医生应密切监测 6MWT 期间的心肺反应。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验